These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7592507)

  • 21. [Treatment with antiepileptics of mentally retarded patients. Experiences from the 1980s a challenge in the 1990s].
    Brodtkorb E
    Tidsskr Nor Laegeforen; 1996 Jan; 116(3):387-91. PubMed ID: 8638270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
    Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
    J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Valproate-caused encephalopathy].
    Thygesen KS; Wolf P
    Ugeskr Laeger; 2005 Oct; 167(40):3793-4. PubMed ID: 16221398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valproate in bipolar disorder: the Canadian perspective.
    Joffe RT
    Can J Psychiatry; 1993 Apr; 38(3 Suppl 2):S46-50. PubMed ID: 8098990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valproate in the treatment of epilepsy in people with intellectual disability.
    Friis ML
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():32-5. PubMed ID: 10030429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the toxicity of valproic-acid.
    Moreiras Plaza M; Rodríguez Goyanes G; Cuiña L; Alonso R
    Clin Nephrol; 1999 Mar; 51(3):187-9. PubMed ID: 10099893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hyperammonemic encephalopathy associated with valproate acid].
    Osuna MT; Burcet J; Ramió L; Ustrell X; Silva Y; Molins A
    Neurologia; 2003; 18(6):347-50. PubMed ID: 12838456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of newly diagnosed epileptic crises. A French experience].
    Groupe CAROLE (Coordination Active du Réseau Observatoire Longitudinal de l'Epilepsie)
    Rev Neurol (Paris); 2001 Dec; 157(12):1500-12. PubMed ID: 11924446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is valproate encephalopathy under-recognised in older people? A case series.
    Beyenburg S; Back C; Diederich N; Lewis M; Reuber M
    Age Ageing; 2007 May; 36(3):344-6. PubMed ID: 17374600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The risk of paradoxical levetiracetam effect is increased in mentally retarded patients.
    Szucs A; Clemens Z; Jakus R; Rásonyi G; Fabó D; Holló A; Barcs G; Kelemen A; Janszky J
    Epilepsia; 2008 Jul; 49(7):1174-9. PubMed ID: 18479387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.
    Alvarez N; Besag F; Iivanainen M
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():1-15. PubMed ID: 10030426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute pancreatitis caused by valproic acid: apropos a case].
    Bahamonde Carrasco A; Morán Blanco A; Olcoz Goñi JL
    Gastroenterol Hepatol; 1996 May; 19(5):253-4. PubMed ID: 8752568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating the incidence of leukopenia and neutropenia with valproate, quetiapine, or the combination in children and adolescents.
    Rahman A; Mican LM; Fischer C; Campbell AH
    Ann Pharmacother; 2009 May; 43(5):822-30. PubMed ID: 19401471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polycystic ovary syndrome in women using valproate: a review.
    Bilo L; Meo R
    Gynecol Endocrinol; 2008 Oct; 24(10):562-70. PubMed ID: 19012099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different clinical manifestations of hyperammonemic encephalopathy.
    Gomceli YB; Kutlu G; Cavdar L; Sanivar F; Inan LE
    Epilepsy Behav; 2007 Jun; 10(4):583-7. PubMed ID: 17412645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valproate-associated pancreatitis.
    Asconapé JJ; Penry JK; Dreifuss FE; Riela A; Mirza W
    Epilepsia; 1993; 34(1):177-83. PubMed ID: 8422855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of bipolar affective illnesses with valproate. A review of the literature].
    Retzow A; Emrich HM
    Psychiatr Prax; 1998 Jul; 25(4):163-71. PubMed ID: 9738242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fish liver oil and propolis as protective natural products against the effect of the anti-epileptic drug valproate on immunological markers of bone formation in rats.
    Elwakkad AS; El Elshamy KA; Sibaii H
    Epilepsy Res; 2008 Jul; 80(1):47-56. PubMed ID: 18455911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sodium valproate as a cause of acute pancreatitis: a case report].
    Barreda L; Rosas J; Milian W; Valdivia D; Targarona J
    Rev Gastroenterol Peru; 2006; 26(3):318-23. PubMed ID: 17053827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.